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Background/aim: This study aimed to analyze the effect of a high-fat and high-fructose diet (HFFD) on the digesta weight and shortchain fatty acid (SCFA) levels of cecal digesta in rats.
Materials and methods: This study was an experimental study with a posttest-only control group design with male Sprague–Dawley
strain rats as the samples. A total of 36 rats were divided into two groups with normal diet (N) and modified HFFD. The data of energy
intake, nutrients and fiber, body weight, Lee index, abdominal circumference, digesta weight, and SCFA levels of cecal digesta were
collected.
Results: The results showed an 11.94% increase in body weights of rats with HFFD. The total energy intake of the HFFD group was
significantly higher than that of N (p = 0.000). The fiber intake and cecal digesta weight in group N were higher than that in the HFFD
group (p = 0.00 and p = 0.02, respectively). The concentrations of acetate, butyrate, propionate, and total SCFA in the N group were
significantly higher than in the HFFD (p = 0.041,,p = 0.004, p = 0.040, p = 0.013, respectively). A significant negative relationship was
observed between the abdominal circumference and cecal digesta concentration (p = 0.029; r = −0.529) and between the Lee index and
the SCFA concentration of cecal digesta (p = 0.036, r = −0.206).
Conclusion: The research results showed that HFFD can reduce the weight and SCFA concentration of the cecal digesta. The negative
relationship between abdominal circumference, the Lee index, and the SCFA concentration indicates the potential role in obesity incidence and metabolic diseases.
Key words: Cecal digesta, diet, high-fat, high-fructose, short-chain fatty acid, SCFA

1. Introduction
Obesity results from the imbalance between the energy
spent and energy intake, which influences various metabolic pathways related to metabolites and hormones [1].
The number of people with obesity has increased, and it is
predicted to increase up to 57.8%, especially for the adult
population in the world in 2030 [2,3]. Current studies suggest that obesity is often accompanied by diseases such as
insulin resistance, dyslipidemia, and hypertension and increases the risk of type 2 diabetes and cardiovascular diseases [4–7]. Based on the data from a basic health research
(Riskesdas) in 2018, the prevalence of obesity increased
from 14.8% in 2013 to 21.8% in 2018 in Indonesia [8].
Several studies explained that increased consumption
of foods and beverages with high-fructose corn syrup
would induce an increase in the obesity prevalence. Fruc-

tose can facilitate the glucose absorption but it will lead to
malabsorption when the fructose content is higher than
glucose. Fructose has a higher potential than sucrose to
generate hepatic uric acid and triglycerides, which causes
fatty liver [9]. Mamikutty et al. reported that rat subjects
had obesity, hypertension, hyperglycemia, and hypertriglyceridemia after drinking water with 20% fructose for 8
weeks [10]. Fructose causes addiction and leptin resistance
in the brain while also decreasing cholecystokinin expression and the growth hormone expression in the ventromedial nucleus. Long-term fructose consumption increases
calorie intake due to loss of satiety signals in the brain,
eventually resulting in obesity [11–13].
A low-fiber diet causes low short-chain fatty acid
(SCFA) production by the intestinal microflora. SCFAs,
such as acetate, propionate, and butyrate, are produced
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through fermentation by intestinal microflora from dietary fibers [11]. One of the roles of the intestinal microflora is to convert the free fatty acids (FFAs) from dietary
fats to other FFAs as their metabolism results, which are
the key factor in energy metabolism [14,15]. Dietary fiber
has a beneficial metabolic effect on body weight, as well as
glucose homeostasis, food intake, and insulin sensitivity
[14,15].
SCFA involvement in energy and lipid metabolism has
gained attention as the potential in controlling metabolic
syndrome. Several studies showed that decreased obesity
and insulin resistance occurred in the experimental animals with a high-fat diet after butyrate-containing food
supplementation [12]. The mechanism that explains the
higher fecal SCFA production in the obese population remains a subject of debate. It could be due to the increased
dietary substrate intake or the consequence of the increased metabolic activity of a certain group of bacteria;
interestingly, some studies show inconsistent results. For
example, Fernandes et al. [16] showed experimental results that are contrary to the results of research conducted
by Lin et al. [17], Weitkunat et al. [18], and Miyamoto et al.
[19]. There was an increase in the diet, but there was also a
decrease in SCFA concentrations.
The controversy over these results prompted researchers to conduct studies on obese rats with a high-fat highfructose diet (HFFD) and measure the weight and concentration of SCFA in the cecum rather than in the feces.
Therefore, the present study aims to analyze the effect of
HFFD administration on digesta weight and SCFA levels
in rat cecum, as only 5%–10% of SCFA is excreted in the
feces [20]. Using the obesity animal model, several factors
related to food can be controlled, and the concentration of
SCFA in the cecum can be analyzed. Thus, this study provides more objective results that could be used as a basis
for creating an experimental animal model of obesity and
nutrition interventions. This study has several differences
with the previous ones: (1) We used Sprague–Dawley rats
while some studies used Wistar rats; (2) We used a high-fat
high-fructose feed while previous studies used high-fat or
high-carbohydrate feed; and (3) We measured the SCFA in
cecal digesta while others measured it in the feces.
2. Materials and methods
This research was conducted from October 2017 until
February 2018. The ethical approval for this research was
obtained from the Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia, No. 368/EC/KEPK/10/2017.
2.1. Materials
The feed was composed of corn starch, dextrin corn starch,
sucrose, soybean oil, casein, egg white, agar, white butter,
beef kidney fat, minerals (AIN-93 M-MX-Mineral Mix),
vitamins (AIN-93 -VX-Vitamin Mix), L-cystine, and choline bitartrate.

2.2. Normal and HFFD diet formulation and feed energy
and content analysis
The manufacturing of modified feed and analysis of energy content and nutrient of the feed were according to the
research by Sulistyowati et al. [21]. Feed ingredients consist of corn starch, dextrin corn starch, sucrose, soybean
oil, casein, egg white, gelatin, white butter, cow kidney fat,
minerals (AIN-93 M-MX-Mineral Mix), vitamins (AIN93 -VX-Vitamin Mix), L-cystine, and choline bitartrate.
All ingredients are mixed together and formed as rat pellets. The compositions of dietary diet modification for the
intervention in making animal models of obesity in this
study are listed in Table 1 [21].
2.3. Animal preparation and experimental
2.3.1. Experimental design
This study used a posttest-only control group design. The
number of replications in this study was determined by the
Federer formula [22]:
(t-1)(n-1)≥15
(1)
where t is the number of the intervention group and n
is the number of repetitions or the number of samples per
group. The number of interventions was 2 in this study;
therefore, the number of replications was at least 16. Then,
a number of the backup experimental unit was added to
anticipate unwanted possibilities, such as death. The correction to the number of replications was based on the
Higgins formula:
1/(1-f)
(2)
with an estimated experimental unit dropout (f) of
10%, the number of subjects needed in this study was 36.

Table 1. Characteristics of initial subjects and the results of normal and HFFD dietary food intervention.
HFFD
(mean ± SD)

p-value

Body weight (g) 246 ± 19.11

245.58 ± 22.06

0.945

Intake (g)

12.23 ± 1.67

6.49 ± 1.52

0.000

Intake fiber (g)

0.35 ± 0.05

0.16 ± 0.04

0.000

0

31.71 ± 7.08

0.000

51.60 ± 7.04

34.59 ± 8.12

0.000

51.60 ± 7.04

66.30 ± 7.26

0.000

261.93 ± 29.30

279.42 ± 33.22

0.140

265.85 ± 10.15

287.65 ± 10.34

0.875

14.64 ± 0.93

15.84 ± 0.41

0.009

Characteristic

Intake (calories
from drinks)
Intake (calories
from diet)
Total intake
(calories)
Final weight (g)
Lee index
Abdominal
circumference
(cm)

Normal
(mean ± SD)

Source: Sulistyowati et al. [21].
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The white rats ((Rattus norvegicus) Sprague–Dawley strain) were obtained from the Animal Laboratory of
Institut Pertanian Bogor. The rats had 200–250 g body
weight, were aged 70–90 days postnatal, male, and healthy.
Rats with abnormal motor movements, those that did not
want to eat and drink, and those that had >10% weight
loss during the adaptation period were excluded from the
study. The Sprague–Dawley was chosen as an obese animal
model because it is quieter and easier to handle. Besides
the fact that the rats can show changes in metabolic status
according to the research objectives, these rats also have a
high survival rate [16,23–27].
Rat cages were placed in an approximately 2-cm-thick
husk mat that was replaced every 3 days. Room temperature was maintained at 25 °C in 12 h of dark and light
cycles. Rats were acclimated for 7 days, fed with normal
rat feed, and given distilled water for drinking ad libitum.
On the 7th day, 18 rats in the intervention group were given HFFD and 30% fructose solution drink for 12 weeks
[23,24]. The administration of a normal diet and HFFD
was conducted for 12 weeks. Maintenance and euthanasia of rats were done following the fixed procedures at the
Institute of Biosciences of Universitas Brawijaya Malang.
2.3.2. Sample collection and preparation
Cecal digesta sample preparation for the SCFA content
and digesta weight analysis was carried out by cecal dissections. The contents of the cecum (digesta) were scraped off
using tweezers and then weighed using an ABK 220-4M
digital scale-Japan. Next, each of the digesta was stored at
–20 °C for the SCFA examination.
2.4. Determination of parameters
2.4.1. Calorie intake
The feed intake was calculated by subtracting the amount
of the given feed (g) and the leftover (g) after 24 h. The
same was applied to the drinks in the HFFD group.
Feed intake = the provided feed (grams) – the leftover feed
(grams)						(3)
Calorie intake was calculated by the amount of feed intake
(g) and 30% fructose solution (mL) multiplied by the energy value of feed N, HFFD, and the 30% fructose solution.
Calorie intake = feed intake (grams) × the energy density
of the feed 					(4)
Total calorie = the feed calorie + the drinks calorie
(5)
2.4.2. Body weight, length, abdominal circumference,
and Lee index
Body weight measurements were carried out by weighing rats with a KERN 440-33N analytical balance (Kern &
Sohn, Germany) once a week. The result was the average of
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the two weighing results. Body length was measured after
the rat was anesthetized with ketamine-xylazine of 75–100
mg/kg + 5–10 mg/kg. The body length was measured from
the tip of the nose to the anus or base of the tail (nasoanal). Abdominal circumference was also measured after
the anesthesia. Abdominal circumference was measured
circularly in the largest part of the abdomen. Body length
and abdominal girth were measured using OneMed 235
metleen (OneMed, Indonesia) with an accuracy of 0.01
cm. Lee index was used to determine the degree of obesity:
Lee index=Body weight (g)0,33/Body length (mm)×1000 (6)
2.4.3. The weight of the cecal digesta
The weight of the cecal digesta was measured by using
KERN ABJ 220-4M (Kern & Sohn, Germany) digital scales
with an accuracy of 0.000 mg.
2.4.4. SCFA levels
The digest samples stored at –20 °C were thawed and 4 mg
of the samples were centrifuged at 10,000 rpm for 15 min.
As much as 2 mL of supernatant was added into a 5-mL
plastic tube and 30 mg of 5-sulphosalicylic acid was added.
The solution was shaken, centrifuged at 3000 rpm for 10
min at 4 °C, and then filtered through a Millipore filter
until the clear liquid was obtained. As much as 1 μL of supernatant was injected into the gas-liquid chromatography
device (Chrompack CP 9002 series 946253, Netherlands)
using a microsyringe. After 9 min, the area of the specified
compound was drawn in the recorder paper. Before the
sample was injected, a standard mixture of acetate, propionate, and butyrate was injected first with a concentration
of 0.025%, 0.05%, 0.3%, and 0.5%, respectively. Then the
regression equation was calculated, which reflected the relationship between the area of acetic acid, propionic, and
butyrate standard (Y) with the concentrations of acetic
acid, propionic, and butyrate standard (X) [16,28–31].
2.5. Data analysis
All observations and measurements were tabulated and
made in the form of mean ± standard deviation (SD). The
differences in the experimental animal characteristics, the
weight of the cecum contents, and the concentration of
SCFA from both groups were analyzed by using an independent t-test at a 95% confidence level. The correlation
between variables was tested by a bivariate test and the relationship was determined using the Pearson’s correlation
test. Data processing and analysis were done in Microsoft
Excel and SPSS version 21 (IBM) for Windows.
3. Results
The characteristics of the initial subjects and the results of
the interventions in this study are presented in Table 1. The
rats had similar body weights at the beginning of the study
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digesta weight (g)

as the mean initial body weights in both groups were not
different (p = 0.945). After the HFFD dietary intervention
for 12 weeks, there was an increase of 12% in the average
body weight, higher than the normal but not statistically
significant (p = 0.140). However, there was a significantly
higher abdominal circumference in the HFFD compared
to the N group (p = 0.009).
The mean digesta weight of rats with N feed was significantly higher than that of rats with HFFD feed (p = 0.02)
(Figure). Meanwhile, the concentration of SCFA in cecal
digesta rat with N feed was significantly higher than in rats
with HFFD (Table 2).
Pearson’s correlation test results show a significant
negative relationship between the abdominal circumference and SCFA concentration (r = −0.529; p = 0.029) while
the negative relationship also showed between the Lee Index and the SCFA concentration of the cecal digesta (r =
−0.204; p = 0.433). The relationships between abdominal
circumference, Lee index, and SCFA concentration are
presented in Table 3.

mean

N

HFFD

1,8266

1,4289

Figure. The average weight of cecal digesta by group.
Table 2. Concentrations of SCFA in rat cecal digesta by group.
Characteristic

N

HFFD

p-value

Acetate (mMol/g)

22.76 ± 6.68

18.18 ± 6.93

0.041

Butyrate (mMol/g)

3.23 ± 1.54

2.72 ± 1.28

0.004

Propionate (mMol/g)

7.31 ± 2.81

5.26 ± 2.09

0.040

26.16 ± 9.94

0.013

Total SCFA (mMol/g) 33.30 ± 8.93

Table 3. Pearson’s correlation coefficient between waist
circumference and SCFA concentration of cecal digesta and
between Lee index and SCFA concentration of cecal digesta.

SCFA

Waist circumference

Lee index

–0.529*

–0.204

*Significant at α = 0.05.

4. Discussion
Several studies explained that an increase in the prevalence
of central obesity occurs along with the increase in consumption of foods and drinks containing high-fructose
corn syrup (HFCS). HFCS is commonly used in a wide
variety of favored food and beverage products such as soft
drinks, pastries, cookies, gums, jelly, and desserts. In the
long run, the addiction effects and leptin resistance due to
the fructose increase the calorie intake because of the loss
of satiety signals in the brain, which in turn, causes overweightness and obesity [26].
The intervention of the HFFD feed was recommended in producing experimental animal models of obesity
[32]. Previous studies presented that the composition of
the HFFD feed is 25%–35% carbohydrate, 50%–70% fat,
15%–25% protein, and 17%–30% fructose solution [23–
25,33]. In this study, the composition of the HFFD feed
was 20.51% carbohydrate, 57.57% fat, and 21.90% protein,
with a fiber content of 24.25 g per 100 g of feed, and 30%
fructose in drinks.
The results indicated that the modified AIN 93 HFFD
did not provide significant changes in body weight. However, there was an 11.94% increase in body weight in the
HFFD group. This result is in line with the previous studies
that showed that the rat had moderate obesity if its body
weight change was 10%–25% higher than those in the N
group [13,34]. Those factors did not show a significant
increase in the body weight because the modified feed
formula still had a higher energy density than the N diet,
about 4.21 Cal/g. According to Miras et al. [35], the average energy density for N feed-in obese rats’ models was
<3.5 Cal/g. In this study, the high energy density of N feed
was due to the use of carbohydrate source material so it
could be easily molded as a mouse pellet [35]. The calorie intake in this study was not different from the result
of Marques et al. [24], which was around 66 calories for
the HFFD group and 51 to 53 calories for the N group.
The calorie intake from the feed in the HFFD group was
lower than in the N group; however, the total calories of
the HFFD group were significantly higher than those of
the N group. The high-calorie intake in the HFFD group
was due to the drink that contained 30% fructose. Besides,
the HFFD feed had less than 60% fat, which was one of the
contributing factors [24].
Fiber intake in the N group was significantly higher
than in HFFD. This was due to the lower fiber content
in the HFFD feed. The HFFD feed generally has low carbohydrate content from dietary fiber [14]. It affected the
weight of the digesta in the rat cecum. The weight of rat cecal digestion with the N diet was significantly higher than
HFFD (p = 0.02). The increasing volume of feces is the effect of the dietary fiber’s metabolism in the digestive tract,
especially in the colon [36].
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Most of the metabolic functions of dietary fiber are related to the colon as the fiber is relatively unchanged in the
stomach and small intestine. Bacterial flora works actively
in the colon. Besides being used to increase the content
and weight/volume of feces, the metabolic products are
used to produce volatile fatty acids (acetate, butyrate, and
propionate), which are the main anions in feces [36,37].
The data obtained from individuals who experienced sudden death showed that the SCFA concentrations in the cecum were around 131 mmol/kg lumen contents, ten times
higher than those in the ileum (13 mmol/kg) [38,39].
The results of this study showed that the rats with N
feed had significantly higher SCFA concentrations in cecal digesta than the HFFD (p = 0.013). The results showed
a high-fiber diet with low fat caused a higher amount of
SCFA feces compared with the low-fiber diet [40]. The majority of acetate is produced by enteric bacteria as a result
of carbohydrate fermentation. Besides, one-third of colonic acetate is synthesized from hydrogen and carbon dioxide or formic acid through the Wood–Ljungdahl pathway
by acetogenic bacteria [41,42]. Three different pathways
used by colon bacteria for propionate formation are the
succinate pathway, the acrylic pathway, and the propanediol pathway [43]. Fermented food fiber with cellulose substrate gives a proportion of 81% of acetate, 13% of propionates and 6% of butyrate. In the fermentation process in
the large intestine, cellulose and pectate will produce the
largest proportion of acetic acid, while hemicellulose potentially produces propionate acid [44]. This study showed
that the amount of produced acetate was higher than propionate and butyrate was the least in quantity.
The results also showed the negative relationship between the increased abdominal circumference, which
showed the degree of visceral obesity, with the decreased
concentrations of cecal digesta (r = −0.529; p = 0.029);
which was also similar to the Lee index with the decrease in the SCFA concentration in the cecal digesta. (r =
−0.204; p = 0.433). These were consistent with Heinritz et
al.’s study [31], which explained that SCFA concentrations
were significantly higher in the administration of low-fat
diets than high-fat; the significance values for acetate, butyrate, and propionate were p = 0.023, p = 0.013, and p =
0.003, respectively.

Similar results were also found by Barczynska et al.
[45], who observed the SCFAs concentration in the feces
of obese children was lower than normal-weight children
(p = 0.04). It can be explained that the SCFA protective
effect on the metabolic changes induced by a high-fat diet
depends on the regulation of proliferator-active peroxisomes (PPARγ); it triggers the changes of lipid synthesis
to lipid oxidation [46]. Interestingly, although the three
intestinal SCFAs have a protective effect on obesity, butyrate and propionate are likely to have a more significant
effect than acetate [47]. Different mechanisms have been
proposed to explain this effect; one of them is the activation of signaling pathways mediated by protein kinases,
such as adenosine monophosphate-activated protein kinases [12,46] or mitogen-activated protein kinases [48].
It has been reported that butyrate and propionate induce
the intestinal hormone production, which can reduce food
intake [47]. Acetate also has been proven to reduce appetite through interactions with the central nervous system
[49]. One mechanism underlying the effect of SCFA on
food intake and satiety is related to the release of intestinal
hormone related to satisfaction, especially GLP-1 and the
peptide YY (PYY). These proteins are secreted by intestinal L cell enteroendocrine, which is found in the distal
ileum and colonic epithelium [50,51]. PYY affects appetite
and satiety by suppressing neuropeptide Y (NPY) and activating the proopiomelanocortin (POMC) neurons in the
hypothalamus or by delaying the gastric emptying process
[52]. In addition to its role as incretin, GLP-1 also regulates the appetite by affecting POMC and NPY neurons
in the hypothalamus which also inhibits gastric emptying
and gastric acid secretion [53–56]. Unfortunately, the secretion from intestinal hormones (PYY and GLP-1) was
not assessed in this study, which became a limitation in
this study.
In conclusion, the administration of HFFD showed a
weight and SCFA concentration reduction in the cecum
contents, which is harmful to health. However, further experimental studies are still needed to get more deep information before it can be applied to the human diet.
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